NetworkNewsBreaks Archive - Page 2071 of 2139

ThursdayMar 23, 2017 9:38 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Audio Interview with NetworkNewsWire

Multifaceted financial news and publishing company NetworkNewsWire this morning announced the online availability of a new audio interview with India Globalization Capital, Inc. (NYSE MKT: IGC) CEO Ram Mukunda. In the interview, Mukunda discusses IGC’s operations and targeted market, as well as leading formulations currently in the company’s development pipeline. “This is a very exciting time for us, an exciting opportunity,” Mukunda noted in the interview. “We believe that we have first-mover advantage in combination therapy, as very few companies are actually working on cannabis-based pharmaceuticals and within that space we believe that we are the only ones working on…

WednesdayMar 22, 2017 2:41 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 22, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: PNPL 36.36% – News: Reports that recent claims of a lawsuit are false BXNG 31.58% – News: Secures two-year, $250,000 licensing and management contract MICT 5.73% – News: Hosting conference call to release Q4, FY 2016 results on March 31 VPRB 5.33% – News: Moving on momentum from recent release of limited edition ProBox kit LWLG 4.48% – News: Appoints new CEO effective May 1 AMMJ 4.48% – News: Announces five active clients have…

WednesdayMar 22, 2017 2:38 pm

NetworkNewsBreaks – InMed Pharmaceuticals (IMLFF) Featured in Forbes Article Discussing Unique Cannabinoid Manufacturing System and Database

InMed Pharmaceuticals (OTCQB: IMLFF) was recently featured in a Forbes article highlighting the company's cannabinoid manufacturing system and database, which is used to map different compounds of cannabinoids to the various diseases they are able to treat. According to the article, InMed’s database appeals to other biotech companies who are now willing to purchase the information. Using its database, InMed has been able to identify two new cannabinoid therapies. Additionally, the company has created a method of biosynthesis for cannabinoids that is comparable to the system used to create synthetic insulin for diabetic patients. The company begins with the cannabinoid…

WednesdayMar 22, 2017 12:35 pm

NetworkNewsBreaks – Sequential Brands Group, Inc. (NASDAQ: SQBG) Names Replacement for Departing CEO; Shares Lower

Shares of Sequential Brands Group (NASDAQ: SQBG) are down 10% after the company this morning named Karen Murray as chief executive officer to replace Yehuda Shmidman, who is stepping down from his position at the company and as a member of the board of directors. Murray has also been appointed to serve as a director of the company. “Karen Murray has outstanding leadership skills and industry experience and she has demonstrated her ability to activate and grow successful brands. We are excited to have an executive of Karen’s caliber join and lead our team at Sequential to grow with us. …

WednesdayMar 22, 2017 12:32 pm

NetworkNewsBreaks – SeeThruEquity Issues Update on FTE Networks, Inc. (FTNW), Increases PT to $2.75

SeeThruEquity has issued an update and increased the price target to $2.75 on shares of FTE Networks’ (OTCQX: FTNW) stock. The update follows the company’s March 9th announcement that it plans to acquire Benchmark Builders, Inc. in a $75 million cash and stock transaction that is expected to close in the second quarter of 2017. In February, FTE filed an application to uplist to the Nasdaq Capital Markets, which is cited in the update by SeeThruEquity as a reason to increase the company’s price target. If approved, being listed on the Nasdaq Capital Market would be a noteworthy development for…

WednesdayMar 22, 2017 12:29 pm

NetworkNewsBreaks – United Health Products, Inc. (UEEC) Covered at SeeThruEquity

SeeThruEquity has issued a preliminary coverage report on United Health Products (OTCQB: UEEC). The report follows the company’s recently filed application with the FDA to expand use indications for its lead product candidate, Hemostyp®, an all-natural hemostatic agent that has demonstrated the ability to quickly control bleeding from open wounds and body cavities. Hemostyp® Topical Hemostatic Dressing is FDA approved as a Class 1 device and is sold in prescription and over-the-counter forms. If approved by the FDA, the indications for Hemostyp® would be expanded to include use in general surgery, opening a new form of revenue for the company.…

WednesdayMar 22, 2017 12:27 pm

NetworkNewsBreaks – MGX Minerals (MGXMF) Takes Aim at Growing Lithium Market With Cheaper Extraction Process

MGX Minerals (OTC: MGXMF) holds the largest lithium portfolio in Canada and has its sights set on the booming global lithium market, projected to reach $5.87 billion by 2020. “Positive developments have made the company’s lithium operations a special point of interest. An important factor is the company’s engineering partner Purlucid Treatment Solutions, which has developed technologies representing a major step in the process of extracting lithium from petroleum brine water (petrolithium). MGX already holds the largest lithium portfolio in Canada, with its Sturgeon Lake property in Alberta and other lithium assets, and the company is the sole proprietary technology…

WednesdayMar 22, 2017 12:24 pm

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) Maintains Steady Focus on Expansion

National Waste Management Holdings (OTC: NWMH) has set what some would consider a lofty objective of four acquisitions per year. With an impressive track record of doing so, however, the management team at National Waste has demonstrated its ability to meet this goal and diversify its revenue streams. “These days, National Waste continues to press forward with an aggressive business model that calls for one acquisition per quarter by seeking out acquisitive opportunities in Upstate New York and Florida. To name a few, the company acquired both Sivart Services, a roll-off and compactor company in Worchester, NY, and Northeast Data…

WednesdayMar 22, 2017 12:22 pm

NetworkNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Shares Spike on Orphan Drug Designation for Annamycin

Moleculin Biotech (NASDAQ: MBRX) shares are 31% higher mid-morning after the company said it has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for Annamycin for the treatment of acute myeloid leukemia (AML). This designation will provide the company several benefits, such as tax credits for qualified clinical trials costs, exemptions from certain FDA application fees, and seven years of market exclusivity upon regulatory product approval. "We are pleased to report this key milestone and the FDA's decision to grant Annamycin orphan drug designation. We look forward to announcing additional milestones in regard to our clinical…

WednesdayMar 22, 2017 11:18 am

NetworkNewsBreaks – TapImmune, Inc. (NASDAQ: TPIV) Announces Participation in Two Upcoming Investor and Industry Conferences

Clinical-stage immuno-oncology company TapImmune, Inc. (NASDAQ: TPIV) today announced plans to participate in two upcoming investor and industry conferences. First, Dr. Glynn Wilson, chairman and CEO of TapImmune, will be offering an overview of the company’s business, clinical pipeline and partnering opportunities for its proprietary PolyStart technology platform at the 5th Annual Cancer Biopartnering & Investment Forum hosted by Sachs Associates in New York City. Wilson’s presentation is scheduled for 10:35 am ET on Tuesday, March 28, 2017. The full presentation will be webcast live and archived for future viewing at http://tapimmune.com/events. Second, Dr. John Bonfiglio, president and chief operating…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks